VolitionRX Ltd (NYSE American:VNRX)

2.98
Delayed Data
As of Feb 16
 +0.01 / +0.34%
Today’s Change
2.08
Today|||52-Week Range
4.71
+1.36%
Year-to-Date
SECTOR
Health Services
INDUSTRY
Medical/Nursing Services
MARKET CAP
$79.0M

Company Description

VolitionRX Ltd. engages in the development of blood-based cancer tests. Its product Nu.Q is a colorectal cancer screening triage test. The company was founded on August 5, 2010 and is headquartered in Singapore.

Contact Information

VolitionRX Ltd.
1 Scotts Road
Singapore Central Singapore 228208
P:
Investor Relations:
(646) 650-1351

Employees

Shareholders

Individual stakeholders22.63%
Other institutional20.12%
Mutual fund holders1.20%

Top Executives

Cameron John ReynoldsPresident, Chief Executive Officer & Director
David Vanston CecilChief Financial Officer & Treasurer
Jason Bradley TerrellChief Medical Officer & Head-US Operations
Jacob Vincent MicallefChief Scientific Officer
Louise DayChief Marketing & Communications Officer